About Augmedix
Augmedix is a Healthcare company based in San Francisco (United States) founded in 2012, and was acquired by Commure in October 2024. AI-powered solutions for medical documentation and clinical support are delivered. It operates on a AI-as-a-Service and Subscription Services model. Augmedix has raised $118.31 million across 12 funding rounds from investors including HCA Healthcare, Kleiner Perkins and McKesson. The company has 133 employees. Its website augmedix.com draws about 16 thousand monthly visits. Its Indian entity Augmedix Solutions Private Limited reported revenue of ₹16.66 Cr. Augmedix offers products and services including Augmedix Go and Emergency Medicine App. Its focus areas include Health Technology and Medical Software. Its competitors include Suki, Abridge Inc and DeliverHealth Solutions; 2 of its 3 listed competitors have raised funding.
Company details
Augmedix is engaged in providing ambient AI solutions for medical documentation across various healthcare settings, including emergency departments and primary care. The companys technology captures patient-clinician conversations and generates accurate medical notes, allowing clinicians to focus on patient interaction. Solutions are tailored to different specialties like oncology and emergency medicine, with customizable levels of AI automation and human support. Security and compliance are prioritized with HITRUST certification and HIPAA adherence. Integration with popular EHR systems is supported to enhance workflow efficiency in hospitals and clinics.
- Headquarters San Francisco, United States
- Employees 133
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website augmedix.com
- Social LinkedIn X Facebook Instagram YouTube
- Acquired by Commure (Oct 2024)
- Legal Name Augmedix
- Date of Incorporation 25 Feb, 2019
- Jurisdiction Bangalore, Karnataka, India
- Indian entity revenue₹16.66 Cr
FY 2025 · 0% YoY
- Indian entity net profit₹1.11 Cr
FY 2025 · 7% margin
- Indian entity EBITDA₹2.30 Cr
FY 2025 · 14% margin
- Total Equity Funding$118.31M (USD)
in 12 rounds
- Latest Funding Round$12M (USD), Post-IPO
Apr 2023
- InvestorsHCA Healthcare
& 18 more
- Employee Count133
- Acquired byCommure
(Oct 2024)
Associated legal entities of Augmedix
Augmedix operates through Augmedix Solutions Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Augmedix Solutions Private Limited CIN U74999KA2019FTC121860 | Active | 25 Feb 2019 | Bangalore, Karnataka | ₹16.7 Cr | 133 | 3 | View details |
Products & Services of Augmedix
Augmedix offers a comprehensive portfolio of products and services, including Augmedix Go and Emergency Medicine App.
Ambient AI generates accurate medical notes for clinicians.
Specialized app handles complex emergency medicine workflows.
Apps and channels of Augmedix
its YouTube channel Augmedix has 71K subscribers and 16 videos.
Videos from Augmedix
The most watched videos on Augmedix's YouTube channel, Augmedix (71K subscribers). Click a video to play it here.
More on Augmedix.
Funding Insights of Augmedix
Augmedix has successfully raised a total of $118.31M across 12 strategic funding rounds. The most recent funding activity was a Post-IPO round of $12 million completed in April 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $118.31M
- Total Rounds 12
- Last Round Post-IPO — $12M
- Investors Count 18
Latest 10 of 12 funding rounds of Augmedix with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr 2023 | $12M | Post-IPO | – | – | |
| Mar 2021 | Debt – Conventional | – | – | ||
| Oct 2020 | $25.91M | Series C | – | Redmile Group, McKesson | – |
| Oct 2019 | $19M | Series B | – | Redmile Group, McKesson Ventures | – |
| Jun 2017 | $10M | Series B | – | – | |
| Dec 2016 | $23M | Series B | – | Orbimed, Redmile Group | – |
| Apr 2016 | $17M | Series B | – | Redmile Group | |
| Jan 2015 | $16M | Series A | – | DCM Ventures, Emergence Capital | |
| Jun 2014 | $4.1M | Seed | – | Emergence Capital, DCM Ventures | – |
| Mar 2014 | $3.2M | Seed | – | Emergence Capital, DCM Ventures | – |
19 investors in total: 19 institutional.
Investors in Augmedix
Augmedix has secured backing from 19 investors, including institutional and venture fund investors. Prominent investors backing the company include HCA Healthcare, Kleiner Perkins and McKesson.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Venture debt firm that does debt investment in the US | eastwardcp.com | Newton, United States | ||
Tech-focused seed, early, and mid-stage VC investments are made globally. | dcm.com | Menlo Park, United States | ||
Investments are directed by McKesson Ventures toward early-stage healthcare startups. | ventures.mckesson.com | San Francisco, United States | ||
Venture capital firm investing in early-stage healthcare companies | wanxianghealthcare.com | Elgin, United States | ||
Venture debt and equipment financing are provided to growth-stage companies. | 2008 | trinitycap.com | Phoenix, United States | |
Investments are made by OrbiMed in global healthcare innovations across biopharmaceuticals and related fields. | 1989 | orbimed.com | New York, United States | |
Tech focused Early and growth stage VC firm investing in the US | emcap.com | San Francisco, United States | ||
Tech focused early-stage micro VC firm investing in the US | greatoaksvc.com | New York, United States | ||
Venture capital firm investing in early-stage tech startups | 1972 | kleinerperkins.com | Menlo Park, United States | |
Venture capital investments are managed in technology and healthcare sectors by this firm. | mdv.com |
Investor details for Augmedix
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Augmedix Solutions Private Limited (Augmedix)
Augmedix Solutions Private Limited is the primary company behind Augmedix. The board of Augmedix Solutions Private Limited currently have 3 directors; the longest-serving is Anuj Bhatia, appointed in 2024. 7 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Anuj Bhatia DIN 10301326 | Director | 28 Oct 2024 | 2 yrs | Augmedix Solutions Private Limited |
| Vaibhav Gupta DIN 08942368 | Director | 28 Oct 2024 | 2 yrs | Augmedix Solutions Private Limited |
| Daniel Michael Brian DIN 09447107 | Director | 28 Oct 2024 | 2 yrs | Augmedix Solutions Private Limited |
People of Augmedix
16 people are tracked at Augmedix (9 in leadership, 7 in board & advisors); the tracked headcount is 133.
| Name | Role | Group |
|---|---|---|
Saurav Chatterjee | Chief Technology Officer | Leadership |
Manny Krakaris | Chief Executive Officer | Leadership |
Ian Shakil | Founder, Director, Chief Strategy Officer | Leadership |
Rashed Noman | Country Director, Bangladesh | Leadership |
Sandra Breber | Chief Operating Officer | Leadership |
Davin Lundquist | Chief Medical Officer | Leadership |
Jonathan Hawkins | Chief Revenue Officer | Leadership |
Paul Ginocchio | Chief Financial Officer | Leadership |
Lia Wallick | Head of People | Leadership |
Jason Krikorian | Independent Director | Board & advisors |
Laurie McGraw | Director | Board & advisors |
Rod O’Reilly | Director | Board & advisors |
Robert Faulkner | Director | Board & advisors |
Joe Marks | Director | Board & advisors |
William Febbo | Director | Board & advisors |
Margie L. Traylor | Director | Board & advisors |
Complete people profiles for Augmedix
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Augmedix
Figures of Augmedix Solutions Private Limited, the primary company behind Augmedix, for FY 2025. Revenue was ₹16.66 Cr (0% year on year). Net profit was ₹1.11 Cr (7% margin). EBITDA was ₹2.30 Cr (14% margin). Revenue has grown at a compounded annual rate of +103% over three years and +45% over five years.
- ₹16.66 CrRevenue · FY 2025 · 0% YoY
- ₹1.11 CrNet profit · 7% margin
- ₹2.30 CrEBITDA · 14% margin
- ₹10 LakhPaid-up capital
- 133Employees (provident fund records)
- +103%Revenue CAGR, 3 years
- +45%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Augmedix Solutions Private Limited are on its company page.
Detailed financial statements for Augmedix
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of Augmedix
5 dated milestones of Augmedix across 12 years, from founding to its latest funding, stage changes and deals.
- Founded Augmedix is founded.
- Funding First funding round.
- IPO Lists on the stock exchange (IPO).
- Funding Latest funding round, Post-IPO, of $12.0M.
- Exit Acquired by Commure.
Competitors of Augmedix
Augmedix has 3 listed competitors in our database, 2 of them funded. They include Suki, Abridge Inc and DeliverHealth Solutions.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| suki.ai | 2017 | Redwood, United States | $165M | 87 | AI-backed voice solutions for medical documentation are provided. | |
| abridge.com | 2018 | Pittsburgh, United States | $778.43M | AI-based platform for recording and managing health conversations is provided. | ||
| deliverhealth.com | 2000 | Burlington, United States | EHR management software is provided for healthcare professionals and organizations. |
Detailed competitors of Augmedix
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Augmedix
The website of Augmedix (augmedix.com) receives about 15.7K visits a month.
- Monthly visits15.7K
▼ 19.7% vs previous month
Websites whose visitors overlap most with Augmedix. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| healthcaredive.com | 100% | #456,431 | View details | ||
| amplifyhealth.com | 43% | 4.4K | #4,633,969 | View details | |
| angel.co | 41% | #722,232 | View details | ||
augmentedplanet.com | augmentedplanet.com | 30% | – |
Top companies in Clinical IT & Data Platforms
3 companies that operate in the same segment as Augmedix (Clinical IT & Data Platforms) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Employee health benefits are facilitated via a cloud-based platform. | 2007 | Plymouth Meeting, Pennsylvania, United States | USD 228.3 M | |||
Healthcare appointments are booked online via Zocdoc's platform. | 2007 | New York, New York, United States | USD 425.97 M | USD 4.66 M | 1,365 | |
Virtual physical therapy and digital pain care solutions are provided. | 2015 | San Francisco, California, United States | USD 854.44 M | 1,746 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Augmedix
Complete news archive for Augmedix
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Augmedix
Augmedix was founded in 2012 and raised its 1st funding round 1 year after it was founded.
Augmedix is headquartered in San Francisco, United States. It is registered at San Francisco, California, United States.
Augmedix is a funded company, having raised a total of $118.31M across 12 funding rounds to date. The company's 1st funding round was a Seed of $3.2M, raised on Jan 2013.
Augmedix has 133 employees.
The primary company behind Augmedix, Augmedix Solutions Private Limited, reported revenue of ₹16.66 Cr for FY 2025, down 0% year on year.
Augmedix is engaged in providing ambient AI solutions for medical documentation across various healthcare settings, including emergency departments and primary care. The companys technology captures patient-clinician conversations and generates accurate medical notes, allowing clinicians to focus on patient interaction. Solutions are tailored to different specialties like oncology and emergency medicine, with customizable levels of AI automation and human support. Security and compliance are prioritized with HITRUST certification and HIPAA adherence. Integration with popular EHR systems is supported to enhance workflow efficiency in hospitals and clinics.
Augmedix's top competitors include Abridge Inc, Suki and DeliverHealth Solutions.
Augmedix offers Augmedix Go and Emergency Medicine App.
Augmedix has 19 investors. Key investors include HCA Healthcare, Kleiner Perkins, McKesson, Commure, and Sutter Health.
Augmedix operates through Augmedix Solutions Private Limited.
Yes. Augmedix was acquired by Commure in October 2024.
The legal entities of Augmedix currently have 3 directors, including Anuj Bhatia, Vaibhav Gupta, Daniel Michael Brian.